FDA expands use window for stroke treatment device

By AuntMinnie.com staff writers

February 15, 2018 -- The U.S. Food and Drug Administration (FDA) has expanded the treatment window for use of medical device company Concentric Medical's Trevo image-guided clot retrieval device for stroke patients.

The device is used as an initial therapy for stroke to reduce paralysis, speech difficulties, and other stroke-related disabilities. Previously, it was cleared for use six hours after the onset of symptoms; the FDA has now expanded this to 24 hours.

Trevo is inserted through a catheter into the blood vessel to the site of the blood clot. A section at the end of the device expands up to 6 mm and grips the clot, allowing the physician to remove it by pulling it back through the blood vessel, the FDA said.

Copyright © 2018 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking